These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2503337

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of intraocular proliferations with intravitreal steroids.
    Machemer R, Sugita G, Tano Y.
    Trans Am Ophthalmol Soc; 1979; 77():171-80. PubMed ID: 545825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of vitreolysis and vitreous detachment with hyaluronidase and perfluoropropane gas.
    Kang SW, Hyung SM, Choi MY, Lee J.
    Korean J Ophthalmol; 1995 Dec; 9(2):69-78. PubMed ID: 8818320
    [Abstract] [Full Text] [Related]

  • 9. X-irradiation in the prevention of experimental post-traumatic vitreous proliferation.
    Belkin M, Avni I, Kessler E, Hercberg A, Spierer A, Treister G.
    Curr Eye Res; 1995 Dec; 2(11):753-6. PubMed ID: 7186856
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF, Tsourdou A, Tzatzarakis MN, Tsika C, Charisis S, Naoumidi I, Plainis S, Tsilimbaris MK.
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Taxol treatment of experimental proliferative vitreoretinopathy.
    Daniels SA, Coonley KG, Yoshizumi MO.
    Graefes Arch Clin Exp Ophthalmol; 1990 Sep; 228(6):513-6. PubMed ID: 1979953
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ocular toxicity of intravitreal tacrolimus.
    Passos E, Genaidy MM, Peyman GA.
    Ophthalmic Surg Lasers; 2002 Sep; 33(2):140-4. PubMed ID: 11942546
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Experimental posterior penetrating eye injury in the rabbit. II. Histology of wound, vitreous, and retina.
    Cleary PE, Ryan SJ.
    Br J Ophthalmol; 1979 May; 63(5):312-21. PubMed ID: 465405
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of intraocular proliferations with intravitreal corticosteroids.
    Tano Y, Sugita G, Abrams G, Machemer R.
    Am J Ophthalmol; 1980 Jan; 89(1):131-6. PubMed ID: 6153251
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy.
    Moritera T, Ogura Y, Yoshimura N, Honda Y, Wada R, Hyon SH, Ikada Y.
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3125-30. PubMed ID: 1399416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.